2026 Q2 -tulosraportti
Vain PDF
6 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 30.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 31.7. | ||
2026 Q1 -tulosraportti 30.4. | ||
2025 Q4 -tulosraportti 30.1. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·2 päivää sittenWhat's happening out among the customers is what's interesting. IF and when John Hopkins starts regular use of RayPilot, the stock price will look different.
·1.8.All listed companies with losses are struggling, and if there is no leverage, some larger owners are having a bit of a tough time if they have, t.e.x. Nordnet and Avanza. If a market capitalization is over 50 milj.kr, they probably have loans, and then the share price level should not fall too quickly. This applies to several companies where there can be large variations in the share price level. What is a reasonable future value - this is what leads to different assessments. I have larger investments in some listed companies where I try to observe ownership changes and who buys/sells and can come in with new valuations for the future. If the share price level falls, then it's important to think carefully. I see more and more "rescue" with "single-share purchases" to maintain the share price level. Opinions welcome.The main owner already has a value of over 50 milj.kr at today's price. Probably there are limits, so my belief that they will buy up is, in my assessment, unlikely. Pressure on the stock for many years. If leveraged, it can become difficult with a lower share price level. Buy for those who believe there are many shares.- ·31.7.On March 24th this year, the share price was 83 öre and perhaps with today's report it will be that level again soon ? Those of us who left a long time ago feel justified.Congratulations on a higher share price with negative results. Hard to understand but perhaps some see more in the future than many others?
- ·8.7.Excellent news about USA and a stock chart that looks positive. The stock is above both 50 and 200 days and a golden cross approaching. Hope lives, but nothing is given.
- ·1.7.This is something I have been waiting for for a very long time: Micropos Medical announces that the first five patients in the USA have been treated with the Raypilot System at Johns Hopkins Medicine as part of an early clinical evaluation. The collaboration is now moving towards a broader clinical implementation."The news from Johns Hopkins is much bigger than it appears at first glance. For a company the size of Micropos, this is one of the most significant clinical milestones to date. It is not a guarantee of a commercial breakthrough – but it is a validation of the technology in one of the world's most prestigious cancer clinical environments, and it can open doors that were previously closed." CoPilot
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
Vain PDF
6 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 päivää sittenWhat's happening out among the customers is what's interesting. IF and when John Hopkins starts regular use of RayPilot, the stock price will look different.
- ·1.8.All listed companies with losses are struggling, and if there is no leverage, some larger owners are having a bit of a tough time if they have, t.e.x. Nordnet and Avanza. If a market capitalization is over 50 milj.kr, they probably have loans, and then the share price level should not fall too quickly. This applies to several companies where there can be large variations in the share price level. What is a reasonable future value - this is what leads to different assessments. I have larger investments in some listed companies where I try to observe ownership changes and who buys/sells and can come in with new valuations for the future. If the share price level falls, then it's important to think carefully. I see more and more "rescue" with "single-share purchases" to maintain the share price level. Opinions welcome.The main owner already has a value of over 50 milj.kr at today's price. Probably there are limits, so my belief that they will buy up is, in my assessment, unlikely. Pressure on the stock for many years. If leveraged, it can become difficult with a lower share price level. Buy for those who believe there are many shares.
- ·31.7.On March 24th this year, the share price was 83 öre and perhaps with today's report it will be that level again soon ? Those of us who left a long time ago feel justified.Congratulations on a higher share price with negative results. Hard to understand but perhaps some see more in the future than many others?
- ·8.7.Excellent news about USA and a stock chart that looks positive. The stock is above both 50 and 200 days and a golden cross approaching. Hope lives, but nothing is given.
- ·1.7.This is something I have been waiting for for a very long time: Micropos Medical announces that the first five patients in the USA have been treated with the Raypilot System at Johns Hopkins Medicine as part of an early clinical evaluation. The collaboration is now moving towards a broader clinical implementation."The news from Johns Hopkins is much bigger than it appears at first glance. For a company the size of Micropos, this is one of the most significant clinical milestones to date. It is not a guarantee of a commercial breakthrough – but it is a validation of the technology in one of the world's most prestigious cancer clinical environments, and it can open doors that were previously closed." CoPilot
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 30.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 31.7. | ||
2026 Q1 -tulosraportti 30.4. | ||
2025 Q4 -tulosraportti 30.1. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 |
2026 Q2 -tulosraportti
Vain PDF
6 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 30.10. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 31.7. | ||
2026 Q1 -tulosraportti 30.4. | ||
2025 Q4 -tulosraportti 30.1. | ||
2025 Q3 -tulosraportti 31.10.2025 | ||
2025 Q2 -tulosraportti 31.7.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·2 päivää sittenWhat's happening out among the customers is what's interesting. IF and when John Hopkins starts regular use of RayPilot, the stock price will look different.
- ·1.8.All listed companies with losses are struggling, and if there is no leverage, some larger owners are having a bit of a tough time if they have, t.e.x. Nordnet and Avanza. If a market capitalization is over 50 milj.kr, they probably have loans, and then the share price level should not fall too quickly. This applies to several companies where there can be large variations in the share price level. What is a reasonable future value - this is what leads to different assessments. I have larger investments in some listed companies where I try to observe ownership changes and who buys/sells and can come in with new valuations for the future. If the share price level falls, then it's important to think carefully. I see more and more "rescue" with "single-share purchases" to maintain the share price level. Opinions welcome.The main owner already has a value of over 50 milj.kr at today's price. Probably there are limits, so my belief that they will buy up is, in my assessment, unlikely. Pressure on the stock for many years. If leveraged, it can become difficult with a lower share price level. Buy for those who believe there are many shares.
- ·31.7.On March 24th this year, the share price was 83 öre and perhaps with today's report it will be that level again soon ? Those of us who left a long time ago feel justified.Congratulations on a higher share price with negative results. Hard to understand but perhaps some see more in the future than many others?
- ·8.7.Excellent news about USA and a stock chart that looks positive. The stock is above both 50 and 200 days and a golden cross approaching. Hope lives, but nothing is given.
- ·1.7.This is something I have been waiting for for a very long time: Micropos Medical announces that the first five patients in the USA have been treated with the Raypilot System at Johns Hopkins Medicine as part of an early clinical evaluation. The collaboration is now moving towards a broader clinical implementation."The news from Johns Hopkins is much bigger than it appears at first glance. For a company the size of Micropos, this is one of the most significant clinical milestones to date. It is not a guarantee of a commercial breakthrough – but it is a validation of the technology in one of the world's most prestigious cancer clinical environments, and it can open doors that were previously closed." CoPilot
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt